MENU
+Compare
DVA
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$123.07
Change
-$0.53 (-0.43%)
Capitalization
8.73B

DVA DaVita Forecast, Technical & Fundamental Analysis

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics... Show more

DVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DVA with price predictions
Nov 12, 2025

DVA's RSI Oscillator ascending out of oversold territory

The RSI Indicator for DVA moved out of oversold territory on November 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where DVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DVA just turned positive on November 12, 2025. Looking at past instances where DVA's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .

DVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DVA as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DVA entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DVA's P/B Ratio (91.743) is very high in comparison to the industry average of (8.474). P/E Ratio (12.755) is within average values for comparable stocks, (113.087). Projected Growth (PEG Ratio) (1.181) is also within normal values, averaging (2.302). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (0.734) is also within normal values, averaging (1.518).

View a ticker or compare two or three
DVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DVA is expected to report earnings to rise 23.51% to $3.10 per share on February 18

DaVita DVA Stock Earnings Reports
Q4'25
Est.
$3.10
Q3'25
Missed
by $0.72
Q2'25
Beat
by $0.17
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.11
The last earnings report on October 29 showed earnings per share of $2.51, missing the estimate of $3.23. With 130.52K shares outstanding, the current market capitalization sits at 8.73B.
A.I. Advisor
published General Information

General Information

a provider of integrated dialysis services for patients suffering from chronic kidney failure

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
2000 16th Street
Phone
+1 720 631-2100
Employees
70000
Web
https://www.davita.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLEKX12.840.03
+0.23%
Victory Pioneer Equ Premium Income R6
VSMPX306.690.17
+0.06%
Vanguard Total Stock Mkt Idx Instl Pls
FIQAX17.95N/A
N/A
Fidelity Advisor Asset Manager 60% Z
FSRKX8.97N/A
N/A
Fidelity Strategic Real Return K6
VCRQX14.92-0.01
-0.07%
NYLI CBRE Global Infrastructure Class R6

DVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DVA has been loosely correlated with UHS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DVA jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVA
1D Price
Change %
DVA100%
+1.09%
UHS - DVA
43%
Loosely correlated
+1.79%
DNTCF - DVA
43%
Loosely correlated
+0.80%
ACHC - DVA
42%
Loosely correlated
-4.55%
HCA - DVA
39%
Loosely correlated
+2.44%
CON - DVA
37%
Loosely correlated
+1.94%
More

Groups containing DVA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVA
1D Price
Change %
DVA100%
+1.09%
Hospital/Nursing Management
industry (88 stocks)
46%
Loosely correlated
-2.24%